Clinical trial
A Multicenter Study of the Safety of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis
NCT00049751 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Study of the Safety of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis
- Lead sponsor
- Abbott
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2002
- Completion date
- Not reported
- Enrollment
- 3,000
- Sites
- 54
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis